MYC and laryngotracheoesophageal cleft: MYC oncogenes are the most commonly amplified loci in MB [29,30] that are generally associated with non-WNT/non-SHH disease (particularly subgroup 3), LC/A histology, and metastatic dissemination, making them known biomarkers of poor prognosis.